Leaderboard

Fr | De
Aucun choix d'articles!     Panier  
Vous êtes ici: Recherche de documentation spécialisée » Estomac / intestins » Néoplasie 23. Juin 2026
Recherche
Gastroplattform
Néoplasie
Recherche avancée
Dépistage / diagnostic
Traitements
Directives
Perfectionnement
Nouvelles
Recherche de documentation spécialisée
Voies biliaires
Foie
Estomac / intestins
Diarrhée
MII (maladie de Crohn/colite)
Troubles fonctionnels
Gastroentérite
Hémorragie digestive
Néoplasie
Ulcère peptique
Autres
Œsophage
Pancréas
Congrès et sessions
Services et outils
Liens
Rect Top
  Écriture: écriture augmenter écriture diminuer

   Page 1 de 12061  Page précédente Page suivante
   
   Articles 1 - 20 / 241201  
   
Preoperative Risk Evaluation for Cancer Treatment (PREdiCT): protocol for an international cohort study evaluating a trimodal screening tool to predict outcomes following gastrointestinal cancer surgery.
BMJ Open
Reeves J, Koh C, Alexander K, Solomon M, Karunaratne S, Petridis A, Carey S, Dhillon H, White K, Pillinger N, Gillis C, Hirst N, Shadid Z, Rahman MI, Boden I, Mahoney A, Woodfield J, Vagg D, De Boer HD, Sutton P, Pereira L, Drummond-Lage AP, Mcloughlin S, Alvarez A, Pirie K, Hii MW, Suliman A, Uçaner B, Schizas D, Nassim K, Albatool R, Ali K, Triantafyllou T, Styliana A, Merlini I, Van Daele E, Mulita F, Bell M, Martinez-Palli G, Koch C, Falconi M, Garmanova T, Deng N, Tirelli F, Lubbers T, Chwat C, Costales A, Hanna NM, Petrova A, Khamees A, Beard D, Granger CL, PREdiCT Study Investigators, Steffens D.
PMID: 42331585 [PubMed - in process]


Immunonutrition Decreases Postoperative Complications in Gastrointestinal Cancer - A Systematic Review and Meta-analysis of Randomized Controlled Trials.
Adv Nutr
Budai BC, Panait R, Laczkó B, Cai G, Váncsa S, Veres DS, Fazekas KK, Szalai EÁ, Hagymási K, Er, Földvári-Nagy L, Hegyi P, Bunduc S.
PMID: 42331289 [PubMed - as supplied by publisher]


Multidimensional regulatory networks of drug resistance in colorectal cancer: from molecular mechanisms to novel therapeutic counterstrategies.
Biochem Pharmacol
Shen J, Ma Y, Wang Y, Yang M, Liang T, Guo L.
PMID: 42331068 [PubMed - as supplied by publisher]


PolyDeep Advance 3: Randomized Clinical Trial comparing PolyDeep-assisted and conventional colonoscopy for adenoma detection rate in a colorectal cancer screening program.
Endoscopy
Davila-Piñón P, Díez-Martín AI, Nogueira-Rodríguez A, Fdez-Riverola F, Glez-Peña D, Reboiro-Jato M, De Castro L, Fernández-De Castro D, Vega P, Galovart-Araguas MT, Soto S, Alonso-Lorenzo S, Martinez-Turnes A, Pin N, Zarraquiños S, Remedios D, Sánchez-Gomez C, Souto-Rodríguez R, Baiocchi F, Iglesias-Varela MJ, Ledo A, Tejido-Sandoval C, Rivas L, García-Morales N, Rodríguez-De Jesus A, Puga M, Castiñeira-Domínguez MB, Fernández-Fernández N, Germade-Martínez A, Gonzalez-De La Ballina E, Pérez-Medrano I, López-Fernández H, Cubiella J.
PMID: 42331035 [PubMed - as supplied by publisher]


Addition of ipilimumab to atezolizumab plus bevacizumab in advanced hepatocellular carcinoma (PRODIGE 81-FFCD 2101-TRIPLET HCC): phase 2 results from a randomised, multicentre, open-label, phase 2-3 trial.
Lancet Gastroenterol Hepatol
Merle P, Blanc JF, Le Malicot K, Peron JM, Bourgeois V, Bouattour M, Touchefeu Y, Vitellius C, Akouz FK, Heurgué A, Girot P, Assenat E, Nguyen-Khac E, Bronowicki JP, Viaud J, Ben Abdelghani M, Manfredi S, Edeline J, Phelip JM, TRIPLET-HCC study investigators.
PMID: 42330996 [PubMed - as supplied by publisher]


Systematic review and Bayesian network meta-analysis comparing multiple anastomotic techniques after total mesorectal excision in rectal cancer.
Eur J Surg Oncol
Kitaguchi D, Forgione A, Serra-Aracil X, Innocenzi C, Yang Y, Giménez M, Oda T, Marescaux J.
PMID: 42330709 [PubMed - as supplied by publisher]


Boundary-Aware Spectral and Morphological Guidance Method for Feature-Driven Colorectal Cancer Segmentation.
IEEE Trans Med Imaging
Lei P, Hu H, Li S, Liu Y, Xie X, Zhan J, Wang K, Guo Y, Liu Z, Qiu B, Chen X.
PMID: 42329941 [PubMed - as supplied by publisher]


Real-World Survival and Toxicity Outcomes of Fluorouracil With vs. Without Leucovorin in Metastatic Colorectal Cancer.
J Gastrointest Cancer
Zengin B, Nazzal J, Salameh M, Akgun S, Dirican CD, Massad A, Bains N.
PMID: 42329513 [PubMed - indexed for MEDLINE]


Positioning Zolbetuximab in HER2-Negative Advanced Gastric Cancer: A Practical Framework for Treatment Selection in the ICI Era.
J Gastrointest Cancer
Sagawa T, Fujikawa K.
PMID: 42329482 [PubMed - indexed for MEDLINE]


Metabolic and nutritional impact of gastrectomy and perioperative treatment in gastric cancer: a prospective cohort study.
J Egypt Natl Canc Inst
Muszy, J, Witalewska A, Gawlewicz-Czepiel A, Polak K, Spieszny M, Richter P, Szczepanik A, Piotr K.
PMID: 42329354 [PubMed - indexed for MEDLINE]


Evaluating pegenzileukin (SAR444245/THOR-707) in combination with pembrolizumab or cetuximab in advanced metastatic gastrointestinal cancer: the PEGATHOR phase 2 study.
Invest New Drugs
Harris WP, García-Alfonso P, Metges JP, Cubillo-Gracian A, Zaanan A, Carlos LL, Ronzoni M, Ponz-Sarvise M, Baakili A, Kefsi A, Andrieu L, Agrawal M, Wang W, Paehler T, Abbadessa G, Van Cutsem E.
PMID: 42329347 [PubMed - as supplied by publisher]


Proximal-to-distal gradient and its implications in differentiation and prognosis in colorectal neuroendocrine neoplasms: the RGETNE-HERACLES study.
Neuroendocrinology
Iglesias Álvarez G, Capdevila J, Garcia-Carbonero R, Jimenez-Fonseca P, Benavent M, Vicente MÁ, Llanos M, López C, Alonso V, García-Centeno R, Crespo G, Alonso-Gordoa T, García Paredes B, Sevilla I, Custodio A, Páez D, Segura A, Gallego J, San Roman M, García-Álvarez A, Alonso Álvarez B, Cacho Lavín JD, Lamarca A, Cano JM, González Florez E, Gómez D, Castaño Á, Carmona-Bayonas A.
PMID: 42328994 [PubMed - as supplied by publisher]


Impact of Sarcopenia on Elderly Patients Undergoing Endoscopic Resection: Scoping Review.
Dig Endosc
Hisada H, Asano H, Tsuji Y, Kubota D, Miura Y, Mizutani H, Ohki D, Takeuchi C, Yakabi S, Niimi K, Kakushima N, Yamamichi N, Fujishiro M.
PMID: 42328932 [PubMed - indexed for MEDLINE]


Serum ferritin as a potential biomarker for distinguishing advanced-stage colorectal cancer: a retrospective cohort study.
PeerJ
Cao C, Tang F, Zhu Z, Wang F, Li J.
PMID: 42328677 [PubMed - indexed for MEDLINE]


Mechanisms and Emerging Strategies to Overcome Immunotherapy Resistance in Cold Tumours of Colorectal Cancer.
Onco Targets Ther
Zhu X, Ge B, Wen L.
PMID: 42328283 [PubMed]


Longitudinal remodeling of gastric microbiota following Helicobacter pylori eradication reveals an eradication-associated microbial signature in gastric cancer.
Front Cell Infect Microbiol
Song CH, Choi Y, Kim N, Ha S, Park JH, Lee HK, Shin CM, Ahn S.
PMID: 42328161 [PubMed - indexed for MEDLINE]


Radiomic Analysis of MRI for Assessing Response to Neoadjuvant Chemoradiotherapy in Rectal Adenocarcinoma: A Systematic Review and Metaanalysis.
Mol Imaging
Jakipov M, Tamadon A, Burkitbayev Z, Kochiev B, Karimov A, Temirbayeva A, Iztleuov Y, Jamwal P, Daneshvar K, Mussin NM, Safarzoda Sharoffidin R.
PMID: 42327954 [PubMed - indexed for MEDLINE]


CDK4/6-targeted therapy for gastrointestinal cancers: from resistance mechanisms to immuno-combination strategies guided by biomarkers.
Front Immunol
Cui J, Zhang Y, Wu Y, Zhang G, Lan J, Wang Y.
PMID: 42327781 [PubMed - indexed for MEDLINE]


Beyond prediction: AI as a mechanistic microscope and digital twin for colorectal cancer immunotherapy.
Front Immunol
Zhou Z, Zhou J.
PMID: 42327774 [PubMed - indexed for MEDLINE]


Macrophage morphology in the tumor microenvironment predicts metachronous liver metastasis in gastric cancer: establishment and validation of a predictive model.
Front Immunol
Wang S, Zheng G, Qiao X, Tian Y, Li R, Dan H, Yang Y, Duan L, Niu L, Yang J, Wu F, Zheng J, Feng F.
PMID: 42327759 [PubMed - indexed for MEDLINE]


   
   Articles 1 - 20 / 241201    Page 1 de 12061  Page précédente Page suivante

 
Rect Bottom
Adserver Footer
 

  Intervalle de temps demandé  
   

Sky right 1